Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus

Citation
Sdjm. Niemeijer-kanters et al., Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus, ATHEROSCLER, 156(1), 2001, pp. 209-216
Citations number
37
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
156
Issue
1
Year of publication
2001
Pages
209 - 216
Database
ISI
SICI code
0021-9150(200105)156:1<209:EOILSO>2.0.ZU;2-Q
Abstract
A preponderance of small dense LDL particles is strongly associated with th e occurrence of atherosclerotic disease. Although several studies have docu mented an increased prevalence of small dense LDL particles in diabetes mel litus no data are available to show the effect of lipid-lowering treatment upon the improvement of LDL particle size. In the present study we examined the effect of lipid-lowering treatment, following an intensive lipid-lower ing strategy for 30 weeks pursuing ADA recommended target lipid levels, on LDL particle size in 50 type 2 diabetic patients with moderate hyperlipidem ia. At week 0, 24 patients (48%) were characterized by small dense LDL phen otype pattern B. After the treatment period a shift towards normal LDL part icle size was observed in 17 patients but seven patients (29%) showed the m ore atherogenic LDL subclass pattern B. After treatment, plasma HDL-cholest erol was significantly lower (P < 0.05) in these patients compared to those who had LDL subclass pattern A. Multivariate regression analysis revealed VLDL-cholesterol or triglycerides and HDL3-cholesterol as independent deter minants for LDL particle size. Change in HDL2-cholesterol was an independen t determinant for change in LDL particle size. In conclusion, a strategy of intensive lipid-lowering, with the intention to reduce triglyceride levels below 1.7 mmol/l, may be insufficient to ensure improvement in LDL size in all patients. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.